ESTA
ESTABLISHMENT LABS HOLDINGS INC.
NASDAQ · Healthcare · Medical - Devices · CR
$65.78
+3.10%Oct 19, 2026, 12:00 UTC
ESTABLISHMENT LABS HOLDINGS INC. said it plans to announce its third-quarter 2026 financial results before the market opens on October 29, 2026, and hold a conference call at 8:30 a.m. ET that day.
Source:Oct 15, 2026, 10:27 UTC
ESTABLISHMENT LABS HOLDINGS INC. and NuSil Technology LLC amended their Master Supply Agreement, extending its initial term to December 31, 2031 and revising terms including pricing, exclusivity, payment, and business continuity.
Sep 21, 2026, 12:00 UTC
Establishment Labs announced product line extensions of its Mia and Preservé offerings with new sizes and supporting tools at the 11th World Symposium on Ergonomic Implants.
Source:Aug 6, 2026, 14:51 UTC
Establishment Labs Holdings Inc. reported a second-quarter loss of $0.39 per share, which was larger than the consensus estimate of a $0.34 loss but improved from a $0.57 loss a year earlier.
Source:Jun 29, 2026, 00:00 UTC
Establishment Labs Holdings Inc. appointed Taylor Harris as a new director, effective June 24, 2026.